JP2022532108A5 - - Google Patents

Info

Publication number
JP2022532108A5
JP2022532108A5 JP2021566070A JP2021566070A JP2022532108A5 JP 2022532108 A5 JP2022532108 A5 JP 2022532108A5 JP 2021566070 A JP2021566070 A JP 2021566070A JP 2021566070 A JP2021566070 A JP 2021566070A JP 2022532108 A5 JP2022532108 A5 JP 2022532108A5
Authority
JP
Japan
Application number
JP2021566070A
Other languages
Japanese (ja)
Other versions
JP2022532108A (ja
JPWO2020225551A5 (https=
JP7617029B2 (ja
Filing date
Publication date
Priority claimed from GBGB1906487.2A external-priority patent/GB201906487D0/en
Priority claimed from GB201914729A external-priority patent/GB201914729D0/en
Priority claimed from GBGB2006286.5A external-priority patent/GB202006286D0/en
Priority claimed from PCT/GB2020/051105 external-priority patent/WO2020225551A1/en
Application filed filed Critical
Publication of JP2022532108A publication Critical patent/JP2022532108A/ja
Publication of JPWO2020225551A5 publication Critical patent/JPWO2020225551A5/ja
Publication of JP2022532108A5 publication Critical patent/JP2022532108A5/ja
Priority to JP2024211835A priority Critical patent/JP2025032205A/ja
Publication of JP7617029B2 publication Critical patent/JP7617029B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021566070A 2019-05-08 2020-05-06 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー Active JP7617029B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024211835A JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1906487.2A GB201906487D0 (en) 2019-05-08 2019-05-08 DNA Marker
GB1906487.2 2019-05-08
GB1914729.7 2019-10-11
GB201914729A GB201914729D0 (en) 2019-10-11 2019-10-11 DNA marker
GB2006286.5 2020-04-29
GBGB2006286.5A GB202006286D0 (en) 2020-04-29 2020-04-29 DNA marker
PCT/GB2020/051105 WO2020225551A1 (en) 2019-05-08 2020-05-06 Chromosome conformation markers of prostate cancer and lymphoma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024211835A Division JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Publications (4)

Publication Number Publication Date
JP2022532108A JP2022532108A (ja) 2022-07-13
JP2022532108A5 true JP2022532108A5 (https=) 2023-05-16
JPWO2020225551A5 JPWO2020225551A5 (https=) 2023-05-16
JP7617029B2 JP7617029B2 (ja) 2025-01-17

Family

ID=70775424

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021566070A Active JP7617029B2 (ja) 2019-05-08 2020-05-06 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー
JP2024211835A Pending JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024211835A Pending JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Country Status (14)

Country Link
US (1) US20230049379A1 (https=)
EP (1) EP3966350A1 (https=)
JP (2) JP7617029B2 (https=)
KR (1) KR20220007132A (https=)
CN (2) CN120591403A (https=)
AU (3) AU2020268861B2 (https=)
CA (1) CA3138719A1 (https=)
GB (3) GB2626699B (https=)
IL (1) IL287597A (https=)
MY (1) MY203765A (https=)
SG (1) SG11202112221TA (https=)
TW (1) TWI873135B (https=)
WO (1) WO2020225551A1 (https=)
ZA (1) ZA202109658B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202302862A (zh) * 2021-03-04 2023-01-16 英商牛津生物力學公眾有限公司 染色體交互作用標記物
WO2025215190A1 (en) * 2024-04-12 2025-10-16 Oxford BioDynamics PLC Method of typing chromosome markers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2704625A1 (en) * 2007-11-08 2009-05-14 University Of Washington Dna microarray based identification and mapping of balanced translocation breakpoints
US10364469B2 (en) * 2014-01-16 2019-07-30 Illumina, Inc Gene expression panel for prognosis of prostate cancer recurrence
WO2016193110A1 (en) * 2015-05-29 2016-12-08 Koninklijke Philips N.V. Methods of prostate cancer prognosis
US11802305B2 (en) * 2015-06-24 2023-10-31 Oxford BioDynamics PLC Detection processes using sites of chromosome interaction
MY190153A (en) * 2016-12-01 2022-03-31 Oxford BioDynamics PLC Application of epigenetic chromosomal interactions in cancer diagnostics

Similar Documents

Publication Publication Date Title
JP2022532108A5 (https=)
CN306452311S (https=)
CN306452759S (https=)
CN305673749S (https=)
CN305677855S (https=)
CN305678667S (https=)
CN305683155S (https=)
CN305688497S (https=)
CN305693690S (https=)
CN305694448S (https=)
CN305694935S (https=)
CN305695698S (https=)
CN305697226S (https=)
CN305700957S (https=)
CN305701058S (https=)
CN305701972S (https=)
CN305703592S (https=)
CN305704086S (https=)
CN305934067S (https=)
CN305934671S (https=)
CN305936668S (https=)
CN306138621S (https=)
CN306141663S (https=)
CN306141676S (https=)
CN306179984S (https=)